Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 488

1.

Guideline implementation and patient-tailoring strategies to improve medication adherence for schizophrenia.

Hudson TJ, Owen RR, Thrush CR, Armitage TL, Thapa P.

J Clin Psychiatry. 2008 Jan;69(1):74-80.

PMID:
18312040
2.

A pilot study of barriers to medication adherence in schizophrenia.

Hudson TJ, Owen RR, Thrush CR, Han X, Pyne JM, Thapa P, Sullivan G.

J Clin Psychiatry. 2004 Feb;65(2):211-6.

PMID:
15003075
3.

The effectiveness of guideline implementation strategies on improving antipsychotic medication management for schizophrenia.

Owen RR, Hudson T, Thrush C, Thapa P, Armitage T, Landes RD.

Med Care. 2008 Jul;46(7):686-91. doi: 10.1097/MLR.0b013e3181653d43.

PMID:
18580387
4.

[Relationships between insight and medication adherence in subjects with psychosis].

Droulout T, Liraud F, Verdoux H.

Encephale. 2003 Sep-Oct;29(5):430-7. French.

PMID:
14615692
5.

Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission.

Valenstein M, Copeland LA, Blow FC, McCarthy JF, Zeber JE, Gillon L, Bingham CR, Stavenger T.

Med Care. 2002 Aug;40(8):630-9.

PMID:
12187177
6.

Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors.

Valenstein M, Blow FC, Copeland LA, McCarthy JF, Zeber JE, Gillon L, Bingham CR, Stavenger T.

Schizophr Bull. 2004;30(2):255-64.

PMID:
15279044
8.

Cost-effectiveness analysis of switching antipsychotic medication to long-acting injectable risperidone in patients with schizophrenia : a 12- and 24-month follow-up from the e-STAR database in Spain.

Olivares JM, Rodriguez-Martinez A, Burón JA, Alonso-Escolano D, Rodriguez-Morales A; e-STAR Study Group..

Appl Health Econ Health Policy. 2008;6(1):41-53.

PMID:
18774869
9.

Factors related to antipsychotic oversupply among Central Texas Veterans.

Yang M, Barner JC, Worchel J.

Clin Ther. 2007 Jun;29(6):1214-25.

PMID:
17692735
10.

A prospective evaluation of adherence to medication in first episode schizophrenia.

Kamali M, Kelly BD, Clarke M, Browne S, Gervin M, Kinsella A, Lane A, Larkin C, O'Callaghan E.

Eur Psychiatry. 2006 Jan;21(1):29-33.

PMID:
16460918
11.
12.

A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia.

Ascher-Svanum H, Zhu B, Faries D, Lacro JP, Dolder CR.

J Clin Psychiatry. 2006 Jul;67(7):1114-23.

PMID:
16889456
13.

Associations between adherence to guidelines for antipsychotic dose and health status, side effects, and patient care experiences.

Dickey B, Normand SL, Eisen S, Hermann R, Cleary P, Cortés D, Ware N.

Med Care. 2006 Sep;44(9):827-34.

PMID:
16932134
14.

An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand.

Maneesakorn S, Robson D, Gournay K, Gray R.

J Clin Nurs. 2007 Jul;16(7):1302-12.

PMID:
17584349
15.
16.

Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care.

Ascher-Svanum H, Faries DE, Zhu B, Ernst FR, Swartz MS, Swanson JW.

J Clin Psychiatry. 2006 Mar;67(3):453-60.

PMID:
16649833
17.

Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.

Barbui C, Kikkert M, Mazzi MA, Becker T, Bindman J, Schene A, Nosè M, Helm H, Thornicroft G, Tansella M.

Psychopathology. 2009;42(5):311-7. doi: 10.1159/000232973.

PMID:
19672133
18.

Results of a randomized controlled trial of intervention to implement smoking guidelines in Veterans Affairs medical centers: increased use of medications without cessation benefit.

Joseph AM, Arikian NJ, An LC, Nugent SM, Sloan RJ, Pieper CF; GIFT Research Group..

Med Care. 2004 Nov;42(11):1100-10.

PMID:
15586837
19.

Antihypertensive medication adherence in the Department of Veterans Affairs.

Siegel D, Lopez J, Meier J.

Am J Med. 2007 Jan;120(1):26-32.

PMID:
17208076
20.

Medication management ability assessment: results from a performance-based measure in older outpatients with schizophrenia.

Patterson TL, Lacro J, McKibbin CL, Moscona S, Hughs T, Jeste DV.

J Clin Psychopharmacol. 2002 Feb;22(1):11-9.

PMID:
11799337

Supplemental Content

Support Center